Cargando…
Brain metastases in malignant teratoma: a review of four years' experience and an assessment of the role of tumour markers.
Between 1973 and 1977, 247 patients with malignant teratoma have been treated in two units in London. Seventeen have developed brain metastases, an overall incidence of 6.2%. The median survival from diagnosis of cerebral metastases is 6 weeks and all patients except one have died. The survivor is d...
Autores principales: | Kaye, S. B., Bagshawe, K. D., McElwain, T. J., Peckham, M. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1979
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009884/ https://www.ncbi.nlm.nih.gov/pubmed/88952 |
Ejemplares similares
-
Tumour-marker levels and prognosis in malignant teratoma of the testis.
por: Germa-Lluch, J. R., et al.
Publicado: (1980) -
Chemotherapy of advanced malignant teratomas.
por: Newlands, E. S., et al.
Publicado: (1980) -
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
por: Kaye, S. B., et al.
Publicado: (1979) -
Childhood rhabdomyosarcoma: experience of the Children's Solid Tumour Group.
por: Kingston, J. E., et al.
Publicado: (1983) -
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
por: Dady, P. J., et al.
Publicado: (1982)